Skip to main content

Collins Stewart Initiates Ardea Biosciences at Buy

Juan Lopez , Benzinga Staff Writer

January 19, 2012 7:13am Comments

Collins Stewart has initiated coverage on Ardea Biosciences (NASDAQ: RDEA) with a Buy rating and $30 price target.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: Collins Stewart Price Target Initiation Pre-Market Outlook Analyst Ratings

Need analyst data?
Click here to see licensing options.

Latest Ratings

View the Latest Analytics Ratings

1	RIVN, LCID: Tesla Leads Used EV Sales In Record-Setting Week As Rivian Misses, Lyf...
2	$DOGE, $ETH: Bitcoin Rises As Fed Governor Backs Three Rate Cuts In 2025...
3	TM, VWAGY: 3 Auto Stocks To Consider As Tariff Troubles Play Out
4	TSLA: Elon Musk's Favorability Rating Among Ame...
5	NVDA, AMD: Nvidia And AMD Reportedly Agree To Pa...
6	ASTS, JD: Retail Investors' Top St...
7	EME, V: Benzinga's 'S...

1	ON: Here's How Much $100 Invested In ON Semiconductor 10 Years Ago Would Be W...
2	BX: Here's How Much $1000 Invested In Blackstone 5 Years Ago Would Be Worth...
3	ASTS: USA Rare Earth Q2 FY2025 Earnings Call Transcript
4	META, AMZN: This 'Netflix Of AI' Lets You Create Shows In Second...
5	BRO: Here's How Much $1000 Invested In Brown & Brown 5...
6	ASTS: AST SpaceMobile Q2 FY2025 Earnings Call Transcript
7	NRG: $100 Invested In This Stock 5 Years Ago Would Be Wor...